First Manhattan’s OptiNose OPTN Stock Holding History

First Manhattan’s Portfolio OPTN Stock Details OPTN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-33	Closed	-$925	–	1649
2022 Q4	$925	Sell	33 -67	-67%	-$2.54K	﹤0.01%	1586
2022 Q3	$5K	Sell	100 -67	-40%	-$3.68K	﹤0.01%	1315
2022 Q2	$9K	Hold	167	–	–	﹤0.01%	1246
2022 Q1	$6K	Hold	167	–	–	﹤0.01%	1360
2021 Q4	$4K	Hold	167	–	–	﹤0.01%	1405
2021 Q3	$7K	Hold	167	–	–	﹤0.01%	1343
2021 Q2	$7K	Buy	167 +140	+519%	+$7.15K	﹤0.01%	1338
2021 Q1	$1K	Sell	27 -73	-73%	-$4.44K	﹤0.01%	1443
2020 Q4	$6K	Buy	+100	New	+$6.13K	﹤0.01%	1194

Other funds holding OPTN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

First Manhattan's OPTN Position: Q1 2023 in Review

First Manhattan sold out of OptiNose (OPTN) in Q1 2023, closing a stake of 33 shares — an estimated $925 sold.

First Manhattan first reported a position in OPTN in Q4 2020 and held it in 9 quarters. The position peaked at $9K in Q2 2022. 62 funds tracked by Wall St. Rank hold OPTN as of Q1 2023.

First Manhattan reported no remaining OptiNose position as of Q1 2023 after selling out during the quarter.
First Manhattan sold 33 OptiNose shares in Q1 2023, an estimated $925.
First Manhattan first reported a position in OptiNose in Q4 2020 and held it in 9 quarters.
First Manhattan's OptiNose position peaked at $9K in Q2 2022.
62 funds tracked by Wall St. Rank held OptiNose as of Q1 2023.

Based on First Manhattan's 13F filing for Q1 2023, filed 15 May 2023.